信邦制药：2025年前三季度净利润约1.52亿元

Group 1 - The core viewpoint of the news is that Xinfang Pharmaceutical reported a decline in both revenue and net profit for the first three quarters of 2025 compared to the previous year [1] - The company's revenue for the first three quarters is approximately 4.266 billion yuan, representing a year-on-year decrease of 6.55% [1] - The net profit attributable to shareholders of the listed company is about 152 million yuan, reflecting a year-on-year decrease of 13.74% [1] - The basic earnings per share is 0.0803 yuan, which is a decrease of 13.38% year-on-year [1] Group 2 - As of the report, Xinfang Pharmaceutical has a market capitalization of 7.5 billion yuan [2]